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For chronic paralytic strabismus with large eyeball 
deviation, there are only a few surgical options includ-
ing recession-resection surgery and muscle transposition. 
Given that full tendon transposition (FTT) augmented 
with posterior scleral fixation suture is very effective but 
complicated, FTT augmented with a posterior intermus-
cular suture (PIMS) has been suggested [1]. However, even 
for strabismus specialists, FTT with PIMS is somewhat 
complicated. We considered a recession-resection surgery 
reinforced with botulinum toxin A chemodenervation as 
another surgical option for chronic paralytic strabismus 
with large deviation.
Here, we compare the effects of recession-resection sur-
gery augmented with botulinum toxin A chemodenerva-
tion with those of FTT augmented with PIMS for patients 
with chronic paralytic horizontal strabismus.
Case Reports
Case 1
A 16-year-old man had a history of radiotherapy for as-
trocytoma. He had left exotropia of 80 prism diopters (PD) 
and left hypertropia of 10 PD. He had a loss of left adduc-
tion, and there was no midline cross. A recession-resection 
procedure of the horizontal recti muscles with inferior dis-
placement was planned for the paralytic eye. A left lateral 
rectus recession of 14.0 mm and left medial rectus resec-
tion of 10.0 mm, combined with intraoperative injection 
of five units botulinum toxin A into the left lateral rectus, 
were performed. One year later, the patient was found to 
have left esotropia of 4 PD and left hypertropia of 6 PD in 
the primary position. No additional procedure was neces-
sary.
Case 2
A 58-year-old man had chronic right third cranial nerve 
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In this case series study, we assessed the effects of recession-resection surgery augmented with botulinum 
toxin A chemodenervation for patients with chronic paralytic horizontal strabismus. In addition, we compared 
these effects with those of full tendon transposition (FTT) augmented with posterior intermuscular suture (PIMS). 
Ten patients who underwent strabismus surgery due to paralytic horizontal strabismus were retrospectively re-
viewed. They received a recession-resection surgery augmented with botulinum toxin A chemodenervation (type 
I surgery) or a FTT augmented with PIMS (type II surgery). The preoperative angle of deviation (AOD) and post-
operative improvement in AOD were compared according to the type of procedure. The preoperative AOD was 
60.00 ± 28.50 prism diopters (PD) for type I surgery and 68.00 ± 27.06 PD for type II (p = 0.421). Improvement in 
AOD was 53.20 ± 25.01 PD for type I surgery and 44.20 ± 18.74 PD for type II (p = 0.548). Recession-resection 
surgery augmented with botulinum toxin A chemodenervation is a concise and effective procedure for treating 
paralytic horizontal strabismus.
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palsy caused by a pituitary gland tumor. A dilated, fixed 
pupil was observed in his right eye. He had right exotropia 
of 45 PD and right hypertropia of 4 PD. Right lateral rectus 
recession of 11.0 mm and right medial rectus resection of 6.0 
mm with inferior displacement, combined with intraopera-
tive injection of 5 units botulinum toxin A into the right 
lateral rectus, were performed. At a 30-month follow-up, 
the alignment was nearly straight in the primary position 
at near and far distances. 
We retrospectively reviewed the medical records of five 
patients who received a recession-resection surgery aug-
mented with botulinum toxin A chemodenervation (type 
I surgery) from January 1998 to December 2007. These 
patients had third cranial nerve palsy with exotropia. All 
surgical procedures were performed by a strabismus spe-
cialist, and the same investigator obtained all the pre- and 
postoperative data. During surgery, five units of botulinum 
toxin A (Botox; Allergan Inc., Irvine, CA, USA) in 0.1 mL 
of saline solution was injected into the recessed horizontal 
rectus muscle after conventional recession-resection. The 
injection was administered slowly under direct visualiza-
tion.
Table 1. Characteristics of patients with recession-resection surgery augmented with botulinum toxin A chemodenervation for 
paralytic strabismus (type I surgery)
Patient no. / sex / age
(yr) Diagnosis
Initial deviation
(PD) Surgery
Follow-up 
(mon)
Final deviation 
(PD)
1 / M / 16 CN3, OS 80  LMR Res 10 mm + 5U BTA, LLR Rec 14 mm 12 4
2 / F / 51 CN3, OS 100  LMR Res 13 mm + 5U BTA, LLR Rec 14 mm 6 18
3 / F / 28 CN3, OS 35  LMR Res 6 mm + 5U BTA, LLR Rec 9 mm 6 12
4 / M / 58 CN3, OD 45  RMR Res 6 mm + 5U BTA, RLR Rec 11 mm 30 0
5 / M / 37 CN3, OD 40  RMR Res 6 mm + 5U BTA, RLR Rec 10 mm 6 0
PD = prism diopters; CN3 = third cranial nerve palsy; OS = oculus sinister; LMR = left medial rectus muscle; Res = resection; BTA = bot-
ulinum toxin A; LLR = left lateral rectus muscle; Rec= recession; RMR = right medial rectus muscle; RLR = right lateral rectus muscle; 
OD = oculus dexter.
PD = prism diopters; CN6 = sixth cranial nerve palsy; OS = oculus sinister; FTT c PIMS = full tendon transposition with posterior inter-
muscular suture; CN3 = third cranial nerve palsy; OD = oculus dexter.
PD = prism diopters.
*Recession-resection surgery augmented with botulinum toxin A chemodenervation; †Full tendon transposition augmented with posterior 
intermuscular suture; ‡Mann-Whitney U-test.
Table 2. Characteristics of patients with full tendon transposition augmented with posterior intermuscular suture for paralytic stra-
bismus (type II surgery)
Patient no. / sex / age (yr) Diagnosis Initial deviation (PD) Surgery Follow-up (mon) Final deviation (PD)
1 / M / 32 CN6, OS 50 FTT c PIMS, OS 24 20
2 / F / 28 CN6, OS 60 FTT c PIMS, OS 6 12
3 / M / 52 CN3, OS 115 FTT c PIMS, OS 6 40
4 / F / 46 CN6, OD 50 FTT c PIMS, OD 6 12
5 / F / 47 CN6, OD 65 FTT c PIMS, OD 8 35
Table 3. Pre- and postoperative angles of deviation
Angle of deviation (PD) Type I surgery* Type II surgery† p-value‡
Preoperative  60.00 ± 28.50  68.00 ± 27.06 0.421
Postoperative 1 wk  0.00 ± 0.00  16.25 ± 14.57 0.114
Postoperative 1 mon  0.80 ± 1.79  12.20 ± 11.58 0.222
Postoperative 6 mon  11.33 ± 7.02  19.00 ± 1.41 0.200
At final follow-up  6.80 ± 7.95  23.80 ± 13.05 0.056
Final improvement  53.20 ± 25.01  44.20 ± 18.74 0.548
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We compared the results with those of FTT augmented 
with PIMS (type II surgery). According to the type of 
procedure, the pre- and postoperative angles of deviation 
(AOD) were compared.  
Tables 1 and 2 provide a summary of the patient charac-
teristics. The mean ages of the type I and type II surgery 
groups were 38.00 ± 16.99 years and 41.00 ± 10.39 years 
(range, 16 to 58 years), respectively. The mean follow-up 
time for all patients was 11.00 ± 8.76 months (range, 6 to 30 
months). 
The data on pre- and postoperative AOD are shown at 
Table 3. The mean preoperative AOD was 60.00 ± 28.50 
PD (type I surgery) and 68.00 ± 27.06 PD (type II surgery) 
(p = 0.421). At preoperative and postoperative 1 week, 1 
and 6 months, and the final follow-up, the AODs were not 
significantly different. In addition, the final improvement 
in AOD was 53.20 ± 25.01 PD (type I surgery) and 44.20 ± 
18.74 PD (type II surgery) (p = 0.548). There were no com-
plications such as a scleral perforation, anterior segment 
ischemia, or ptosis in any of the cases during the surgical 
procedure or in the postoperative follow-up period. All sta-
tistical analyses including the Mann-Whitney U-test were 
performed with SPSS ver. 15.0 (SPSS Inc. Chicago, IL, 
USA).
Discussion
The surgical goal for chronic paralytic strabismus is to 
center the field of single binocular vision and to align the 
eyeballs in primary and down-gaze positions. Although 
the surgical choice usually depends on the amount of re-
sidual muscle function, a large recession-resection surgery 
or transposition of recti muscles may be selected. 
Previously, Ozkan et al. [2] reported the effect of intra-
operative botulinum toxin A injection combined with con-
ventional horizontal recti muscle surgery in ten patients 
with infantile esotropia, nonrefractive accommodative 
esotropia, partial accommodative esotropia, basic esotro-
pia, basic exotropia, and sensory exotropia. 
According to neurophysiological studies, botulinum 
toxin A applied to the periphery could directly affect cen-
tral circuits via retrograde transport [3]. In addition to pre-
venting muscle contracture, botulinum toxin A injection 
causes permanent alteration in the muscle and influences 
the peripheral and central nervous systems. Kranjc et al. [4] 
studied the long-term changes of extraocular muscles after 
botulinum toxin A injection into the medial rectus muscles 
of adult rats. These changes occurring in the horizontal 
rectus muscles after botulinum toxin A chemodenervation 
may be responsible for the permanent additive effect of 
botulinum toxin A. 
In our cases, the patients had large exotropia with chron-
ic third cranial nerve palsy. There was a loss of adduction 
and no midline cross. We performed simple recession-
resection surgery accompanied by intraoperative botu-
lium toxin A chemodenervation. Our results show that a 
recession-resection surgery augmented with botulinum 
toxin A chemodenervation had a similar effect to that of 
FTT augmented with PIMS. Even though FTT augmented 
with PIMS is relatively simple and safe compared to other 
surgeries for chronic paralytic strabismus with large devia-
tion, it may be technically more difficult than a recession-
resection surgery. Thus, our recession-resection surgery 
augmented with botulinum toxin A chemodenervation 
technique is a good surgical option. However, due to the 
small number of patients, the present study has limited 
statistical validity. Well-designed prospective studies are 
needed to compare botulinum toxin A treatment to stan-
dard surgical management.
In conclusion, the recession-resection surgery augmented 
with botulinum toxin A chemodenervation is as effective 
as FTT augmented with PIMS for treating paralytic hori-
zontal strabismus.
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